128 related articles for article (PubMed ID: 17108237)
1. Human multidrug resistance protein 2 transports the therapeutic bile salt tauroursodeoxycholate.
Gerk PM; Li W; Megaraj V; Vore M
J Pharmacol Exp Ther; 2007 Feb; 320(2):893-9. PubMed ID: 17108237
[TBL] [Abstract][Full Text] [Related]
2. Estradiol 3-glucuronide is transported by the multidrug resistance-associated protein 2 but does not activate the allosteric site bound by estradiol 17-glucuronide.
Gerk PM; Li W; Vore M
Drug Metab Dispos; 2004 Oct; 32(10):1139-45. PubMed ID: 15280218
[TBL] [Abstract][Full Text] [Related]
3. Functional analysis of nonsynonymous single nucleotide polymorphisms of multidrug resistance-associated protein 2 (ABCC2).
Megaraj V; Zhao T; Paumi CM; Gerk PM; Kim RB; Vore M
Pharmacogenet Genomics; 2011 Aug; 21(8):506-15. PubMed ID: 21691255
[TBL] [Abstract][Full Text] [Related]
4. Mrp2 is essential for estradiol-17beta(beta-D-glucuronide)-induced cholestasis in rats.
Huang L; Smit JW; Meijer DK; Vore M
Hepatology; 2000 Jul; 32(1):66-72. PubMed ID: 10869290
[TBL] [Abstract][Full Text] [Related]
5. Estradiol-17 beta-D-glucuronide (E-17G) cholestasis in perfused rat liver: fate of E-17G and choleretic responses to bile salts.
Utili R; Tripodi MF; Adinolfi LE; Gaeta GB; Abernathy CO; Zimmerman HJ
Hepatology; 1990 May; 11(5):735-42. PubMed ID: 2347547
[TBL] [Abstract][Full Text] [Related]
6. Modulation of human multidrug resistance protein (MRP) 1 (ABCC1) and MRP2 (ABCC2) transport activities by endogenous and exogenous glutathione-conjugated catechol metabolites.
Slot AJ; Wise DD; Deeley RG; Monks TJ; Cole SP
Drug Metab Dispos; 2008 Mar; 36(3):552-60. PubMed ID: 18079363
[TBL] [Abstract][Full Text] [Related]
7. Altered localization and activity of canalicular Mrp2 in estradiol-17beta-D-glucuronide-induced cholestasis.
Mottino AD; Cao J; Veggi LM; Crocenzi F; Roma MG; Vore M
Hepatology; 2002 Jun; 35(6):1409-19. PubMed ID: 12029626
[TBL] [Abstract][Full Text] [Related]
8. Transport of ethinylestradiol glucuronide and ethinylestradiol sulfate by the multidrug resistance proteins MRP1, MRP2, and MRP3.
Chu XY; Huskey SE; Braun MP; Sarkadi B; Evans DC; Evers R
J Pharmacol Exp Ther; 2004 Apr; 309(1):156-64. PubMed ID: 14722317
[TBL] [Abstract][Full Text] [Related]
9. ATP-dependent transport of bile salts by rat multidrug resistance-associated protein 3 (Mrp3).
Hirohashi T; Suzuki H; Takikawa H; Sugiyama Y
J Biol Chem; 2000 Jan; 275(4):2905-10. PubMed ID: 10644759
[TBL] [Abstract][Full Text] [Related]
10. Multidrug resistance protein 2-mediated estradiol-17beta-D-glucuronide transport potentiation: in vitro-in vivo correlation and species specificity.
Herédi-Szabó K; Glavinas H; Kis E; Méhn D; Báthori G; Veres Z; Kóbori L; von Richter O; Jemnitz K; Krajcsi P
Drug Metab Dispos; 2009 Apr; 37(4):794-801. PubMed ID: 19118132
[TBL] [Abstract][Full Text] [Related]
11. Evidence for two interacting ligand binding sites in human multidrug resistance protein 2 (ATP binding cassette C2).
Zelcer N; Huisman MT; Reid G; Wielinga P; Breedveld P; Kuil A; Knipscheer P; Schellens JH; Schinkel AH; Borst P
J Biol Chem; 2003 Jun; 278(26):23538-44. PubMed ID: 12702717
[TBL] [Abstract][Full Text] [Related]
12. Steroid and bile acid conjugates are substrates of human multidrug-resistance protein (MRP) 4 (ATP-binding cassette C4).
Zelcer N; Reid G; Wielinga P; Kuil A; van der Heijden I; Schuetz JD; Borst P
Biochem J; 2003 Apr; 371(Pt 2):361-7. PubMed ID: 12523936
[TBL] [Abstract][Full Text] [Related]
13. Involvement of Mrp2 (Abcc2) in biliary excretion of moxifloxacin and its metabolites in the isolated perfused rat liver.
Ahmed S; Vo NT; Thalhammer T; Thalhammer F; Gattringer KB; Jäger W
J Pharm Pharmacol; 2008 Jan; 60(1):55-62. PubMed ID: 18088505
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of membrane cholesterol content on the transport activity of multidrug resistance-associated protein 2 (ABCC2) and of the bile salt export pump (ABCB11).
Guyot C; Hofstetter L; Stieger B
Mol Pharmacol; 2014 Jun; 85(6):909-20. PubMed ID: 24711118
[TBL] [Abstract][Full Text] [Related]
15. Disruption of function and localization of tight junctional structures and Mrp2 in sustained estradiol-17beta-D-glucuronide-induced cholestasis.
Mottino AD; Hoffman T; Crocenzi FA; Sánchez Pozzi EJ; Roma MG; Vore M
Am J Physiol Gastrointest Liver Physiol; 2007 Jul; 293(1):G391-402. PubMed ID: 17463180
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms involved in spironolactone-induced choleresis in the rat. Role of multidrug resistance-associated protein 2.
Ruiz ML; Villanueva SS; Luquita MG; Sánchez-Pozzi EJ; Crocenzi FA; Pellegrino JM; Ochoa JE; Vore M; Mottino AD; Catania VA
Biochem Pharmacol; 2005 Feb; 69(3):531-9. PubMed ID: 15652244
[TBL] [Abstract][Full Text] [Related]
17. MDR1 substrates/modulators protect against beta-estradiol-17beta-D-glucuronide cholestasis in rat liver.
Liu Y; Huang L; Hoffman T; Gosland M; Vore M
Cancer Res; 1996 Nov; 56(21):4992-7. PubMed ID: 8895755
[TBL] [Abstract][Full Text] [Related]
18. Transcellular transport of organic anions across a double-transfected Madin-Darby canine kidney II cell monolayer expressing both human organic anion-transporting polypeptide (OATP2/SLC21A6) and Multidrug resistance-associated protein 2 (MRP2/ABCC2).
Sasaki M; Suzuki H; Ito K; Abe T; Sugiyama Y
J Biol Chem; 2002 Feb; 277(8):6497-503. PubMed ID: 11748225
[TBL] [Abstract][Full Text] [Related]
19. Functional analysis of dog multidrug resistance-associated protein 2 (Mrp2) in comparison with rat Mrp2.
Ninomiya M; Ito K; Horie T
Drug Metab Dispos; 2005 Feb; 33(2):225-32. PubMed ID: 15507541
[TBL] [Abstract][Full Text] [Related]
20. Coproporphyrin-I: A Fluorescent, Endogenous Optimal Probe Substrate for ABCC2 (MRP2) Suitable for Vesicle-Based MRP2 Inhibition Assay.
Gilibili RR; Chatterjee S; Bagul P; Mosure KW; Murali BV; Mariappan TT; Mandlekar S; Lai Y
Drug Metab Dispos; 2017 Jun; 45(6):604-611. PubMed ID: 28325716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
